Profusa (NVACW) Gains from Investment Securities (2022 - 2026)
Profusa (NVACW) reported Gains from Investment Securities of $244000.0 for Q1 2026, up 24500.0% on a YoY basis from N/an in Q1 2025, and up 126.87% quarter-over-quarter from -$908000.0 in Q4 2025.
Profusa (NVACW) Gains from Investment Securities (2022 - 2026) Analysis & Trends
Profusa has reported Gains from Investment Securities for 5 years, with the latest figure at $244000.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities rose 24500.0% year-over-year to $244000.0; the trailing twelve-month figure through Mar 2026 stood at $4.4 million (up 239.93% YoY), and the FY2025 full-year result was $12527.0, down 8.6% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $244000.0, up from -$908000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $5.9 million in Q2 2025, with the low at -$3.1 million in Q4 2024.
- Historically, Gains from Investment Securities has averaged -$169563.9 across 5 years, with a median of -$304575.0 in 2024.
- Annual changes were most pronounced in 2024 — Gains from Investment Securities sank 509.12% — and 2026, when it surged 24500.0%.
- Profusa's Gains from Investment Securities stood at -$111338.0 in 2022, then plunged by 359.02% to -$511069.0 in 2023, then slumped by 509.12% to -$3.1 million in 2024, then surged by 70.83% to -$908000.0 in 2025, then jumped by 126.87% to $244000.0 in 2026.
- The last three Gains from Investment Securities figures came in at $244000.0 (Q1 2026), -$908000.0 (Q4 2025), and -$884000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Profusa | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 244,000.00 |
| Mar 31, 2026 | 244,000.00 |
| Dec 31, 2025 | -908,000.00 |
| Dec 31, 2025 | -908,000.00 |
| Sep 30, 2025 | -884,000.00 |
| Sep 30, 2025 | -884,000.00 |
| Jun 30, 2025 | 5.92 Mn |
| Jun 30, 2025 | 5.92 Mn |
| Mar 31, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -3.11 Mn |
| Dec 31, 2024 | -3.11 Mn |
| Sep 30, 2024 | -304,575.00 |
| Sep 30, 2024 | -304,575.00 |
| Jun 30, 2024 | 295,872.00 |
| Jun 30, 2024 | 295,872.00 |
| Mar 31, 2024 | 16,509.00 |
| Mar 31, 2024 | 16,509.00 |
| Dec 31, 2023 | -511,069.00 |
| Dec 31, 2023 | -511,069.00 |